SNS Financial Group, LLC
- SEC CIK
- 0001557485
- Latest filing
- Aug 11, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by SNS Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q4 2023 | 20,000 | $186.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 20,000 | $131.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20,000 | $162.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20,000 | $171.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 20,000 | $185.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 20,000 | $206.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 20,000 | $200.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 20,000 | $246.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 20,000 | $347.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 20,000 | $359.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 20,000 | $457.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 20,000 | $299.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.